Product Description
Ipamorelin | 10mg
Researching Growth Hormone Signaling and Recovery
What It Does
Ipamorelin is a selective growth hormone secretagogue being studied for its ability to stimulate natural GH release through ghrelin receptor activation. It is a focus in research exploring recovery, sleep quality, and body composition, often in combination with GHRH analogs to enhance physiologic GH signaling.
What Researchers Explore
- Pulsatile growth hormone release patterns
- Lean muscle development and recovery pathways
- Appetite signaling and nutrient utilization
- Body composition and fat metabolism
- Sleep quality and duration mechanisms
- Collagen production and tissue support
Technical Background
Ipamorelin (Aib-His-D-2-Nal-D-Phe-Lys-NH2) is a pentapeptide with a molecular weight of 711.9 Da and is one of the most selective growth hormone secretagogues identified. It acts as an agonist at the ghrelin receptor (GHS-R1a), stimulating GH release from the pituitary.
Research demonstrates high selectivity for GH secretion with minimal interaction with other endocrine pathways, including ACTH, cortisol, prolactin, and FSH. It promotes pulsatile GH release patterns that more closely resemble natural physiological secretion.
Common Research Applications
- Selective GH secretion mechanism research
- Pulsatile GH release pattern studies
- Bone growth and development models
- Endocrine selectivity and signaling research
- Growth hormone secretagogue structure-activity studies
- Metabolic and recovery pathway research
Product Properties
Purity: 99%+ HPLC
Form: Lyophilized Powder
Size: 10mg
Molecular Weight: 711.9 Da
Category: Growth Hormone Research
Frequently Studied Together
- CJC-1295 NO DAC + Ipamorelin (growth hormone signaling research)
- Sermorelin (GHRH analog research)
- Tesamorelin (GH pathway and metabolic research)
- IGF-1 LR3 (growth factor signaling research)